HHS Is Driving A Paradigm Change Through The Pharmaceutical Industry. What It May Mean For Consumers
To the extent direct-to-consumer advertising helps raise patient awareness of new options, that is useful. But no ad can ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Here's what to know about the anticipated consumer impact of the new tariffs, according to experts: In a social media post ...
These companies are investing heavily into their pipelines and the payoff for long-term investors can be substantial.
President Donald Trump announced a deal with Pfizer to lower drug prices for some Americans. The White House is also ...
AbbVie is a sector mainstay that had no fewer than 12 drugs with net sales above $1 billion last year. It also paid a generous dividend. 10 stocks we like better than AbbVie › It isn't easy to find a ...
President Donald Trump announced Thursday that brand-name or patented pharmaceutical products will be subject to a 100% ...
Some pharmaceutical companies dream of developing and launching one blockbuster drug that will sustain it. Going by full-year 2024 sales, AbbVie had no fewer than 12 of them, a lineup that includes ...
StockStory.org on MSN
Supernus Pharmaceuticals (SUPN) Stock Is Up, What You Need To Know
What Happened? Shares of specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) jumped 4.6% in the morning ...
Trump is set to announce a deal with AstraZeneca to cut U.S. drug prices using a “most-favored-nation” pricing model.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results